IPIRA Startups

nEye.ai is a next-generation optical switch company. Their MEMS-based silicon photonics optical circuit switches (OCS) eliminate critical bottlenecks in AI processing by enabling direct optical connections among thousands of GPUs and memory units. The company's SuperSwitch is an ultra-low power consumption, high radix, compact chip-scale design, offering hyperscale data centers enhanced performance, efficiency, and scalability.

UC Berkeley Professor of Electrical Engineering and Computer Sciences, and Co-Director of Berkeley Sensor and Actuator Center and Berkeley...

Stylus Medicine has created a new gene editing technology based on viral proteins called recombinases. These proteins naturally insert large swaths of DNA into bacterial genomes, but Stylus used machine learning to design recombinases that target specific regions of the human genome. The method is based on the pioneering work of Patrick Hsu, UC Berkeley assistant professor of bioengineering and co-founder and a core investigator of the Arc Institute. The company is on a mission to develop next-generation therapies for disease through genome engineering and chromatin...

2Blades was established as a 501(c)3 charitable organization to implement practical uses of important innovations in plant science that address the rising incidence of crop disease. Working together with world leading scientists in plant-pathogen interactions, 2Blades has scouted and supported the most significant advances in the understanding of plant disease and immunity, as well as enabling technologies to develop disease resistant crops.

Remarkable advances have been realized in plant science over the past twenty years, including genome sequencing,...

Gene and cell therapies for cancer.

Adam Schieferecke, John Dueber, David Schaffer, Juan Eduardo Hurtado, Hyun-Cheol Lee

Wanichaya Noiwangklang, Adam Schieferecke (UC Berkeley, Ph.D., Doctor of Philosophy, Mollecular and Cellular Biology), Juan Hurtado, Hyuncheol Lee, David Schaffer, John Dueber